Immunowake

Private

Birmingham, AlabamaHealthcare & Life Scienceshttps://immunowake.com/

Last Round

Early Funding

Nov 25, 2025

Total Funding Raised

$23M

Company Overview

Immunowake is a biotechnology company that develops cytokine-based agonists and bi-specific antibodies for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryimmunotherapybi-specific antibodiesimmunocytokinesantibody engineeringfusion proteincancer therapypre-clinical researchbiotech pipelineoncology therapeuticsVEGF trapCD3 platformdrug licensingbiologicscell-based assaybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immunowake Comps

Public and private peers based on sector, stage, and business model.

Immunowake comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Immunowake Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Nov 25, 2025
Series A	May 1, 2022
Seed	Aug 22, 2019

View all Funding Rounds

Immunowake Investors

Notable investors and investment history

Immunowake investors
Investor	Rounds
Heda Ventures	Series A
Lapam Capital	Series A
Hyfinity Investments	Series A
HEDA Ventures	Series A

View all Investors

Immunowake Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Immunowake Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Immunowake's valuation, stock price, and market status.

Firmographic Details

HeadquartersBirmingham, Alabama

Employee Range2

Year Founded2019

Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.